Business · 27/02/2012
FDA Releases Draft Guidance on Oversight of Positron Emission Tomography (PET) Drug Products
The Food and Drug Administration (FDA) has published a draft guidance document addressing questions and answers related to the approval and surveillance of PET drug products, covering various aspects such as application submission, review, and compliance with manufacturing practices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →